Cargando…
Fenofibrate for COVID-19 and related complications as an approach to improve treatment outcomes: the missed key for Holy Grail
INTRODUCTION: Fenofibrate is an agonist of peroxisome proliferator activated receptor alpha (PPAR-α), that possesses anti-inflammatory, antioxidant, and anti-thrombotic properties. Fenofibrate is effective against a variety of viral infections and different inflammatory disorders. Therefore, the aim...
Autores principales: | Alkhayyat, Shadi Salem, Al-kuraishy, Hayder M., Al-Gareeb, Ali I., El-Bouseary, Maisra M., AboKamer, Amal M., Batiha, Gaber El-Saber, Simal-Gandara, Jesus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9360649/ https://www.ncbi.nlm.nih.gov/pubmed/35941297 http://dx.doi.org/10.1007/s00011-022-01615-w |
Ejemplares similares
-
Dipyridamole and adenosinergic pathway in Covid-19: a juice or holy grail
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022) -
Hyperviscosity syndrome in COVID-19 and related vaccines: exploring of uncertainties
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022) -
The Potential Nexus between Helminths and SARS-CoV-2 Infection: A Literature Review
por: Al-kuraishy, Hayder M., et al.
Publicado: (2023) -
Changes in the Blood Viscosity in Patients With SARS-CoV-2 Infection
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022) -
Citicoline and COVID-19: vis-à-vis conjectured
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022)